Literature DB >> 30541990

The effect of mesenchymal stem cells on osteoclast precursor cell differentiation.

Takaharu Abe1, Keisuke Sumi1, Ryo Kunimatsu1, Nanae Oki1, Yuji Tsuka1, Kengo Nakajima2, Kazuyo Ando2, Kotaro Tanimoto1.   

Abstract

Transplantation of mesenchymal stem cells (MSCs) has been extensively studied in the field of regenerative medicine. Bone regeneration is achieved via the interaction of osteoblasts and osteoclasts. However, the influence of MSCs on osteoclasts is unknown. The purpose of this study was to investigate the effect of MSCs on the expression of genes for osteoclast differentiation factors using qPCR after indirect co-culture of MSCs and RAW264 cells. The numbers of osteoclasts after addition of soluble receptor activator of nuclear factor kappa B (NF-κB) ligand (sRANKL) were also compared. Expression of osteoprotegerin (OPG) by MSCs was significantly elevated in co-culture over time. The differentiation of RAW264 cells into mature osteoclasts following addition of sRANKL was significantly inhibited by co-culture with MSCs. Expression of RANK, colony stimulating factor 1 receptor, NF-κB, and nuclear factor of activated T-cell cytoplasmic 1 in RAW264 cells was significantly inhibited by co-culture with MSCs. Expression of OPG protein was higher in co-culture with RAW264 cells than in MSCs alone, and the expression level was clearly higher than that of RANKL. MSCs appeared to inhibit osteoclast differentiation via expression of OPG.

Entities:  

Keywords:  bone regeneration; differentiation; mesenchymal stem cell; osteoclast precursor cell

Mesh:

Substances:

Year:  2018        PMID: 30541990     DOI: 10.2334/josnusd.17-0315

Source DB:  PubMed          Journal:  J Oral Sci        ISSN: 1343-4934            Impact factor:   1.556


  5 in total

1.  Apoptotic mesenchymal stromal cells support osteoclastogenesis while inhibiting multinucleated giant cells formation in vitro.

Authors:  Paul Humbert; Meadhbh Á Brennan; Julien De Lima; Régis Brion; Annie Adrait; Céline Charrier; Bénédicte Brulin; Valérie Trichet; Yohann Couté; Frédéric Blanchard; Pierre Layrolle
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

Review 2.  Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.

Authors:  Jehan J El-Jawhari; Payal Ganguly; Elena Jones; Peter V Giannoudis
Journal:  Bioengineering (Basel)       Date:  2021-05-17

3.  Human perivascular stem cells prevent bone graft resorption in osteoporotic contexts by inhibiting osteoclast formation.

Authors:  Stefano Negri; Yiyun Wang; Takashi Sono; Seungyong Lee; Ginny Ching-Yun Hsu; Jiajia Xu; Carolyn A Meyers; Qizhi Qin; Kristen Broderick; Kenneth W Witwer; Bruno Peault; Aaron W James
Journal:  Stem Cells Transl Med       Date:  2020-07-22       Impact factor: 6.940

Review 4.  Mesenchymal stromal cells for osteonecrosis.

Authors:  S Elgaz; H Bonig; P Bader
Journal:  J Transl Med       Date:  2020-10-20       Impact factor: 5.531

Review 5.  Tissue Engineering Strategies for Treating Avascular Necrosis of the Femoral Head.

Authors:  Sumit Murab; Teresa Hawk; Alexander Snyder; Sydney Herold; Meghana Totapally; Patrick W Whitlock
Journal:  Bioengineering (Basel)       Date:  2021-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.